Delivery formulations

Ensysce teams up with Quotient to develop opioid that prevents abuse, overdose

12-Sep-2022 By Nick Taylor

Ensysce Biosciences has partnered with Quotient Sciences to develop an opioid to prevent abuse and overdose, enabling it to make mid-study changes to the formulation based on emerging data.

Precision delivery device offers hope for menstrual migraine patients

08-Sep-2022 By Jenni Spinner

Impel Pharmaceuticals’ Trudhesa treatment, paired with its Precision Olfactory Delivery system, reportedly shows promise to women suffering from the condition.

Vaderis exits stealth as ex-Almac Discovery candidate enters clinical development

07-Sep-2022 By Nick Taylor

The clinical-stage biotechnology company is working on the advancement of a treatment for a blood vessel disorder that it licensed from the other company

People on the Move: September 2022

01-Sep-2022 By Jenni Spinner

This month’s announcements of appointments, acquisitions, new hires, and other news include Standigm, Astellas Pharma, Trialbee, and other key companies.

Market demands, trends impacting APIs and excipients: MilliporeSigma

31-Aug-2022 By Jenni Spinner

An expert from the company discusses how ever-changing patient needs and other dynamic factors are likely to impact pharma ingredient trends down the road.

Synthetic bio company Antheia raises $40m, announces new pilot plant

31-Aug-2022 By Jenni Spinner

The synthetic biology company which specializes in producing ingredients for plant-inspired medicines has a pilot-scale manufacturing facility in the works.

Syneos joins with physIQ, InCarda on atrial fibrillation study

30-Aug-2022 By Jenni Spinner

The physIQ monitoring platform will be used to evaluate an inhaled treatment, developed by InCarda, that is intended to treat atrial fibrillation patients.

Cutting ‘pain points’ can streamline chemical reporting: ACD/Labs

30-Aug-2022 By Jenni Spinner

A representative from the R&D tech provider offers advice on how to wrangle with a stressful, complicated process for better results and fewer headaches.

Celanese lands Gates Foundation grant for refillable contraceptive research

29-Aug-2022 By Jenni Spinner

The company has landed funding from the Bill and Melinda Gates Foundation for research and development on a prototype of a refillable contraceptive solution.

Impel Pharmaceuticals reports progress with ASD-related drug trial

29-Aug-2022 By Jenni Spinner

The company reports dosing of the first subject in a Phase IIa proof-of-concept study investigating a drug for an autism spectrum disorder related condition.

Outsourcing strategists thinking farther ahead than ever: CPHI

23-Aug-2022 By Jenni Spinner

The group’s latest report glimpses inside the minds of pharma leaders, who are looking at a product’s full life-cycle development at the preclinical stage.

Auransa, Polaris harness AI, quantum computing to discover cancer drugs

16-Aug-2022 By Jenni Spinner

The AI and QC specialists have joined to use AI and QC in order to discover biological pathways relevant to the treatment of triple-negative breast cancer.

Merck partners with Cerevance on Alzheimer’s research initiative

11-Aug-2022 By Jenni Spinner

The pharmaceutical company has inked a strategic collaboration with the drug discovery firm, centering on uncovering novel targets in Alzheimer’s disease.

J&J, Evotec partner on ectodomain shedding drug discovery project

11-Aug-2022 By Jenni Spinner

Janssen has formed a strategic collaboration with the drug discovery specialist that involves applying TargetAlloMod platforms to protein homeostasis.

Pfizer to acquire sickle cell disease specialist for $5.4b USD

08-Aug-2022 By Jenni Spinner

Biopharmaceutical company Global Blood Therapeutics specializes in conditions that often disproportionately impact underrepresented communities, such as SCD.

Pharmanovia taps Nanoform to improve bioavailability of ‘iconic branded medicine’

08-Aug-2022 By Nick Taylor

The pharmaceutical company has forged a partnership with the nanotechnology specialist to use nanoparticle tech and formulation to advance its products.

Novasep-PharmaZell commits nearly$7.5m to boosting API capacity

01-Aug-2022 By Jenni Spinner

The contract development and manufacturing organization plans to invest €7.3m to expand and upgrade API production capacity at its Mourenx, France facility.

Tech Innovations: July 2022

21-Jul-2022 By Jenni Spinner

This month’s announcements on new products, tech partnerships, and more includes DiMe, Evonik, Advarra, Curebase, ObvioHealth, and other notable companies.

Clene links ALS prospect to improved survival in open-label study

21-Jul-2022 By Nick Taylor

The biotechnology company has reported its candidate for treating amyotrophic lateral sclerosis patients has shown promising results in an early-phase study.

Vetter kicks off operations at fill-and-finish facility in Austria

13-Jul-2022 By Jenni Spinner

The contract development and manufacturing organization has begun fulfilling customer orders at its new clinical manufacturing facility in Rankweil, Austria.

On-demand cleanrooms help pharma manufacturers ‘fail fast’

13-Jul-2022 By Jenni Spinner

A representative from life-science services company Azzur Group explains how flexibility and speed can help in reaching the best solution more efficiently.

People on the Move: July 2022

11-Jul-2022 By Jenni Spinner

This month’s announcements of launches, appointments, and partnerships includes Saama, COTA, Yourway, Eversana, Kindeva, and other notable industry companies.

Eli Lilly gets speedy NICE recommendation for breast cancer treatment

06-Jul-2022 By Jenni Spinner

England's cost-effectiveness watchdog has recommended Eli Lilly’s Verzenios treatment as an option for adjuvant treatment of certain forms of breast cancer.

bio 2022

BIO unveils its executive committee directors for 2022-2023 term

16-Jun-2022 By Jenni Spinner

The Biotechnology Innovation Organization elected the fresh slate of leaders during the BIO International Convention, taking place in San Diego this week.

Sanofi hemophilia A drug lands breakthrough therapy designation

06-Jun-2022 By Jenni Spinner

Efanesoctocog alfa is an investigational factor III therapy designed to prevent bleeds and bleeding episodes in patients diagnosed with the rare disorder.

People on the Move: June 2022

02-Jun-2022 By Jenni Spinner

This month’s announcements of awards, investments, executive appointment, and expansions include Javara, Thread, uMotif, Lonza, and other notable companies.

How Lithuania aims to become a leading European biotech hub

01-Jun-2022 By Ben Hargreaves

Lithuania’s life sciences industry is growing at one of the fastest rates in Europe. Ahead of BIO, Innovation Agency Lithuania explains what the country’s plans are for future growth in the area and how this is built upon students heading into STEM studies.

Lilly invests $2.1bn in new Indiana manufacturing sites

31-May-2022 By Rachel Arthur

Eli Lilly and Company plans to expand its manufacturing footprint in Indiana by investing $2.1bn in two new manufacturing sites at Indiana's LEAP Lebanon Innovation and Research District in Boone County.

Standigm uses AI to discover potential Crohn’s disease treatment

24-May-2022 By Jenni Spinner

The drug company, which uses artificial intelligence to discover and advance repurposed drugs, is harnessing the technology to find a treatment for Crohn’s.

Regeneron and Sanofi’s Dupixent FDA-approved for eosinophilic esophagitis

23-May-2022 By Jenni Spinner

The approval is the first that the Food and Drug Administration has granted for a drug intended to treat eosinophilic esophagitis, a chronic immune disorder.

NIH awards $577m to antiviral drug developers

20-May-2022 By Rachel Arthur

The National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health, has awarded a total of $577m to establish nine Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern.

Novartis looks to work more strategically as CDMO

16-May-2022 By Jane Byrne

Novartis has recently set up a new contract development and manufacturing unit called Global Biotech Co-operations (GBTC).

AstraZeneca metastatic breast cancer treatment secures FDA approval

10-May-2022 By Jenni Spinner

The US agency has approved Enhertu for patients diagnosed with HER2-positive metastatic breast cancer previously treated with an anti-HER2-based regimen.

Charles River, Valo join on AI-enabled drug discovery offering

10-May-2022 By Nick Taylor

The CRO has paired with the drug discovery technology firm on Logica, an artificial intelligence tool designed to accelerate development of new treatments.

TFF: Phase I study of inhalable COVID-19 drug shows promise

09-May-2022 By Jenni Spinner

The thin-film freezing specialist reports positive safety and pharmacokinetic data coming out of the Phase I trial of its niclosamide inhalation powder.

Illumina secures drug discovery tie-ups with Janssen, Deerfield

09-May-2022 By Jane Byrne

Illumina has recently announced a 10-year-long strategic collaboration with Janssen Biotech, and a five-year partnership with Deerfield Management.

People on the Move: May 2022

05-May-2022 By Jenni Spinner

This month’s news on partnerships, appointments, expansions, and investment includes Javara, ACG, Phastar, Elligo Health Research, and other notable companies.

CPHI North America

Future drugs will need novel excipients: IPEC

04-May-2022 By Jenni Spinner

An expert from the organization discusses ahead of his CPhI North America presentation how tomorrow’s drugs can’t all be formulated with yesterday’s excipients.

CPhI North America 2022

Continuous manufacturing adoption continues to rise: Pharmatech

04-May-2022 By Jenni Spinner

An expert from Pharmatech Associates offers a glimpse into the evolution of CM and previews a lively discussion during the upcoming CPhI North America event.

CPhI North America 2022

Pharma growth, partnerships focus of 2022 CPhI North America

04-May-2022 By Jenni Spinner

A leader from the organizer of the pharmaceutical event discusses what’s in store for the upcoming conference, and for the drug development industry itself.

FDA approves expanded indication for ADHD treatment from Supernus

02-May-2022 By Jenni Spinner

The agency has approved an expanded indication for Qelbree extended-release capsules to treat attention deficit hyperactivity disorder in younger patients.

Sionna raises $111m to take molecules against CF target into the clinic

28-Apr-2022 By Nick Taylor

Newly launched life sciences company Sionna Therapeutics has secured funding to fuel discovery and development of drug candidates to treat cystic fibrosis.

FDA approves Gilead's COVID-19 treatment for young children

26-Apr-2022 By Jenni Spinner

The US agency has expanded its approval of Veklury to include use in pediatric patients 28 days and older who have tested positive for the COVID-19 virus.

Impel Pharmaceuticals upper-nasal delivery offers hope for migraine patients

26-Apr-2022 By Jenni Spinner

The company’s Precision Olfactory Delivery technology, currently combined with its Trudhesa migraine treatment, reportedly facilitates high absorption rates.

HPAPI Summit hones in on pharmaceutical manufacturing risk

25-Apr-2022 By Jenni Spinner

The 2022 edition of the Highly Potent Active Pharmaceutical Ingredients Summit (June 28 to 30 in Boston) will take on a range of topics, including safety.

FDA approves label update to ViiV’s long-acting HIV treatment

25-Apr-2022 By Jenni Spinner

The US Food and Drug Administration has approved a move to make the oral lead-in period for ViiV Healthcare’s once-every-other-month drug Cabenuva optional.

Catalent to invest $350m to expand US drug substance and product manufacturing site

22-Apr-2022 By Jane Byrne

Catalent has announced a multi-year $350m investment at its facility in Bloomington, Indiana, to expand biologics drug substance and drug product manufacturing capabilities.

Lonza expands API development capacity at Nansha, China plant

21-Apr-2022 By Jenni Spinner

The pharma manufacturing specialist is increasing capacity at its development and manufacturing labs to meet growing global demand for highly potent APIs.

Advanced analytic tools can improve safety reporting: IQVIA

20-Apr-2022 By Jenni Spinner

An expert from the health tech company explains how AI, natural language processing, and other tools can improve pharmaceutical product safety reporting.

Inke to triple capacity for inhalation API manufacturing

20-Apr-2022 By Jenni Spinner

The maker of active pharmaceutical ingredients for inhaled treatments is investing €9m ($9.8m USD) to expand its manufacturing plant in Barcelona, Spain.